Review
Open access
Sep 2026
CRISPR Technologies in Type 2 Diabetes: From Mechanistic Insights to Therapeutic Discovery
Type 2 diabetes (T2D) is a complex metabolic disorder driven by the interplay of genetic susceptibility, β-cell dysfunction, and insulin resistance. Although genome-wide association studies (GWAS) have identified numerous T2D risk loci, translating these genetic findings into biological mechanisms and therapeutic strat...
Shuang-Shuang Fan, Rui-Pu Liang, T. Fei
· International Journal of Mol... · 0 citations